The Interprofessional Medication Assessment for Older Patients
The Interprofessional Medication Assessment for Older Patients - a Multicenter Randomized Trial in Primary Care Setting
調査の概要
詳細な説明
Aging increases the risk of adverse effects and interactions caused by medication. Medication reconciliation and medication review are well-known practices to optimize medicines use. Both interventions usually require a team-based approach to be effective. Medication reconciliation is the process of obtaining and documenting a complete and accurate list of current patient medications and comparing this list with medication orders at each point of care transition to identify and rectify any discrepancies before patient harm occurs. Medication review is the process of evaluating current medication treatment to manage the risk and optimize the outcomes of medication treatment by detecting, solving, and preventing medication-related problems. The present study focuses on medication assessment including both medication reconciliation and review combined to clinical assessment of an individual patient.
According to a systematic review there is a need for research focusing on medication management in community settings and especially to assess the impact of medication assessment on clinical outcomes.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Forssa、フィンランド、FI 30100
- Welfare district of Forssa
-
Haapajärvi、フィンランド、FI 85800
- Selänne Basic Health Care District
-
Juva、フィンランド、FI-51900
- Juva Health Care
-
Lahti、フィンランド、FI-15100
- City of Lahti, home care
-
Savonlinna、フィンランド、FI-57100
- Eastern Savo Hospital District
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
Home dwelling ≥65 years-old persons registered to public home care services and who
- have had dizziness, orthostatic hypotension or have fallen or
- use at least six medicines
Exclusion Criteria:
Home care is not responsible for patient's medication, for example due to severe chronic illness (for example severe renal insufficiency or cancer with active treatment in secondary or tertiary care).
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:支持療法
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
アクティブコンパレータ:Active comparator
In addition to usual care, participants allocated to intervention group will receive medication assessment and treatment plan based on it
|
Intervention
|
介入なし:Usual care
Usual care (reference group).
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
---|---|
Functional capacity IADL (Instrumental Activities of Daily Living)
時間枠:at 6 months from baseline
|
at 6 months from baseline
|
Functional capacity ADL (Activities of daily living;KATZ)
時間枠:at 6 months from baseline
|
at 6 months from baseline
|
Functional capacity TUG (Timed up and go)
時間枠:at 6 months from baseline
|
at 6 months from baseline
|
Functional capacity MMSE ( Mini-mental state examination)
時間枠:at 6 months from baseline
|
at 6 months from baseline
|
Functional capacity GDS (Geriatric Depression Scale)-15
時間枠:at 6 months from baseline
|
at 6 months from baseline
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Use of health care services
時間枠:at 6 and 12 months from baseline
|
visits to physician, hospital days and nursing care at home
|
at 6 and 12 months from baseline
|
Need of services delivered to home
時間枠:at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
Number of medicines
時間枠:at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
Quality of medicines
時間枠:at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
Cost of medicines
時間枠:at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
Health related quality of life assessed with EQ-5D
時間枠:at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
協力者と研究者
捜査官
- スタディチェア:Pekka Mäntyselkä, MD、Professor
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- ILMA
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。